PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of subabusetppBioMed CentralBiomed Central Web Sitesearchsubmit a manuscriptregisterthis articleSubstance Abuse Treatment, Prevention, and PolicyJournal Front Page
 
Subst Abuse Treat Prev Policy. 2011; 6: 34.
Published online 2011 December 30. doi:  10.1186/1747-597X-6-34
PMCID: PMC3267651

Difficulty accessing crack pipes and crack pipe sharing among people who use drugs in Vancouver, Canada

Abstract

Background

Crack pipe sharing can increase health risks among people who use drugs, yet the reasons for sharing these pipes have not been well described. Therefore, we sought to identify the prevalence and correlates of crack pipe sharing among a community-recruited sample of people who use illicit drugs in Vancouver, a setting where crack pipes are provided at low or no cost.

Findings

Data for this study were derived from two prospective cohorts of people who use drugs: the Vancouver Injection Drug Users Study (VIDUS) and the AIDS Care Cohort to evaluate Exposure to Survival Services (ACCESS). Multivariate logistic regression was used to identify factors independently associated with crack pipe sharing. Among 503 crack users, 238 (47.3%) participants reported having shared a crack pipe in the previous six months. Having acquired a mouthpiece in the last six months (adjusted odds ratio [AOR] = 1.91; 95% confidence interval [CI]: 1.31 - 2.79) and difficulty finding new pipes (AOR = 2.19; 95%CI: 1.42 - 3.37) were positively associated with pipe sharing. Binge drug use (AOR = 1.39; 95%CI: 0.96 - 2.02) was marginally associated with sharing pipes.

Discussion

There was a high prevalence of crack pipe sharing in a setting where crack pipes are distributed at low or no cost. Difficulty accessing crack pipes was independently and positively associated with this behavior. These findings suggest that additional efforts are needed to discourage crack pipe sharing as well as increase access to crack pipes.

Keywords: crack cocaine smoking, injection drug use, harm reduction, sharing drug paraphernalia

Introduction

Crack cocaine use continues to be associated with various health-related harms. Injuries such as blisters, sores, and cuts on the lips and gums are common among people who smoke crack [1], and crack use has been associated with hepatitis C virus (HCV) and human immunodeficiency virus (HIV) infection [2,3]. There is evidence suggesting that injuries to the oral mucosa promote the transmission of HCV when crack smoking paraphernalia are shared between individuals with oral lesions [4]. However, in the case of HIV, the transmission pathways have not been determined and may reflect elevated syringe sharing or unsafe sex among crack users [2,5]. Other studies have pointed to crack use as a potential mode for the transmission of other infectious diseases including tuberculosis [6,7]. However, increasing access to crack pipes may reduce the frequency of injecting and by extension, blood-borne disease transmission among this population [8].

There is growing support for programs that facilitate access to sterile and safer crack smoking paraphernalia [8,9]. However, these programs remain controversial, and in Canada a number of these programs have been shutdown in response to concerns expressed by policy makers and the public [10,11]. Despite these developments and the high prevalence of crack cocaine use in settings throughout North America [2,12,13], little is known about why people who smoke crack continue to engage in risky behavior such as crack pipe sharing. Further, although past research has revealed that problems with access to sterile syringes can drive syringe sharing in settings where large needle exchange programs operate [14], little is known about the relationship between crack pipe access and crack pipe sharing. Therefore, we sought to investigate crack pipe sharing and access in Vancouver, Canada, a setting where crack smoking is prevalent and where crack pipes are provided at no or low cost.

Background

Vancouver has experienced a massive growth in crack use over the past decade [12]. According to the 2010 Canadian Alcohol and Drug Use Monitoring Survey, the prevalence of crack cocaine use in BC (6.9%) is higher than in any other province [15]. A study in Vancouver demonstrated that among a sample of drug-using participants, daily crack use increased from 7.4% in 1996 to 42.6% in 2005. In the same study, crack use was independently associated with several characteristics, including sex work involvement and unstable housing [12]. Crack cocaine smoking has also been associated with the acquisition of HIV infection among people who inject drugs (IDU) in the city [2].

Locally, crack smoking paraphernalia, including Pyrex pipes, plastic mouthpieces and wooden push sticks, are provided through the BC Centre for Disease Control (BCCDC). A mouthpiece made of clear vinyl tubing is used as an attachment for crack pipes as a means of reducing risks for blood-borne disease transmission and other harms [16]. Wooden push sticks are used as an alternative to plastic syringe plungers, which are often used when packing a screen into a pipe [17]. Distributing wooden sticks helps reduce the likelihood that melted plastic is inhaled and also prevents the misuse and discarding of syringes [17]. Crack pipes in the form of hollow glass tubes are available at some harm reduction distribution sites in Vancouver at no or low cost, but are not universally available for free throughout the city. Local stores also sell crack pipes in areas where crack smokers live or congregate.

Methods

Data for this study were derived from two prospective cohorts involving people who use drugs: the Vancouver Injection Drug Users Study (VIDUS) and the AIDS Care Cohort to evaluate Exposure to Survival Services (ACCESS). The methods for these studies have been previously described [18,19]. In brief, beginning in May 1996, participants were recruited through street outreach and self-referral in the Greater Vancouver Regional District. VIDUS eligibility criteria included having injected illicit drugs at least once in the previous month. ACCESS eligibility criteria included being HIV-positive, and having used illicit drugs other than cannabinoids in the previous month. At baseline visit and semi-annually thereafter, participants complete an interviewer-administered questionnaire and provide blood samples. The questionnaire elicits information about socio-demographic characteristics, drug use and other behavioral patterns, income-generation practices, engagement with medical and addiction treatment services, law enforcement encounters, and other experiences with the criminal justice system. At each study visit participants were provided with an honoraria ($20 CAD). The study has received ethics approval from the University of British Columbia/Providence Health Care Research Ethics Board. The present analyses were restricted to participants who reported smoking crack cocaine in the last six months, and were seen between December 2010 and May 2011. We selected the most recent follow-up period due to recent changes to the crack pipe distribution program in Vancouver. Specifically, we wanted to characterize current rates of sharing among this subpopulation in the wake of these programmatic changes. The collection of these data is being used to inform program development for crack users.

For the present analyses, we used univariate and multivariate logistic regression, with the outcome being having reported crack pipe sharing in the last six months. In this instance, crack pipe sharing referred to either crack pipe borrowing or lending. Variables considered included: median age, gender, living in the Downtown Eastside (DTES) of Vancouver (yes vs. no), frequency of crack use (≥ once per day vs. < once per day), having acquired a mouthpiece (yes vs. no), difficulty accessing crack pipes (yes/sometimes vs. no), smoking crack in public (always/usually vs. sometimes/occasionally/never), and binge use of non-injection drugs (yes vs. no). All behavioral variables refer to behaviors in the past six months. The variable "having acquired a mouthpiece" referred to obtaining a sterile mouthpiece from sites distributing crack pipe supplies. Additionally, the variable "difficulty accessing pipes" referred to whether participants found it difficult to obtain new crack pipes when they needed them. "Binge use of non-injection drugs" referred to whether the participant used non-injection drugs more than usual. To examine bivariate associations, we used the Pearson χ2 test. Fisher's exact test was used when one or more cells contained values less than or equal to five. We then built a multivariate logistic regression model to identify independent predictors of crack pipe sharing by including all variables that were associated with the outcome at the p ≤ 0.10 level in bivariate analyses. All p-values were two-sided. As a subanalysis, we asked participants to specify where they acquired their crack pipes.

Results

In total, 503 drug users reporting crack cocaine smoking in the past six months participated in this study, including 181 (36.0%) females. These participants represented 61.1% of the total number of participants who were recruited into both VIDUS and ACCESS cohorts for this study period. The median age of participants was 46 years (range = 23 - 72 years). In total, 238 (47.3%) reported having shared a crack pipe in the last six months. As well, 63.6% were active injection drug users and 60.6% reported having been in alcohol or drug treatment in the past six months. As indicated in Table Table1,1, factors significantly and positively associated with crack pipe sharing included having acquired a mouthpiece, difficulty accessing crack pipes, and binge use of non-injection drugs. Additionally, age was negatively associated with pipe sharing (all p < 0.10).

Table 1
Bivariate analyses of factors associated with crack pipe sharing among people who smoke crack cocaine (n = 503)

As indicated in Table Table2,2, in multivariate analyses, factors that remained positively associated with crack pipe sharing included: having acquired a mouthpiece and difficulty accessing crack pipes (p < 0.05). Participants reported access to crack pipes through a variety of sources, including: street (new) (39.4%), corner store (29.8%), a drug user-run organization (25.6%), and local health programs (8.2%). As well, a number of participants (9.9%) reported acquiring used pipes from the street.

Table 2
Multivariate logistic regression analyses of factors associated with crack pipe sharing among people who smoke crack cocaine (n = 503)1

Discussion

In the present analyses, we found a high rate of crack pipe sharing among illicit drug users in Vancouver, with just under 50% of participants reporting crack pipe sharing in the previous six months. Those participants who reported sharing crack pipes were more likely to report having recently acquired a mouthpiece and to have experienced difficulty accessing pipes.

Our findings are consistent with previous studies reporting high rates of crack pipe sharing among people who smoke crack [8]. Although there is limited evidence concerning the impact of programs that target crack smokers, a study in Ottawa, Canada reported positive outcomes from distributing crack-smoking paraphernalia, including a decline in the frequency of pipe sharing [8]. Given the health risks associated with pipe sharing and our finding that difficulty accessing pipes was associated with sharing, increasing access to crack pipes has potential to reduce the transmission of infectious diseases as well as injuries to the oral cavity via use of makeshift devices [4,6].

Recent efforts have been made by BCCDC to distribute mouthpieces province-wide. Mouthpiece distribution provides a point of engagement for crack smokers who may not inject since many may not have been connected with harm reduction services otherwise [16]. In the event where crack pipes are unavailable, and sharing a pipe becomes inevitable, mouthpieces can alleviate the risk of injuries and infections associated with pipe sharing. Consistently, our findings showed a positive association between mouthpiece acquisition and sharing crack pipes, indicating that many people who smoke crack are practicing safer smoking methods. However, it is unclear whether individuals are using their own mouthpiece when sharing pipes. Given the lack of evidence describing the negative health consequences from sharing a mouthpiece, future research should focus on examining the different health risks between individuals who share and do not share mouthpieces.

This study has limitations. First, because of the cross-sectional design, determining a temporal relationship between exposure and outcome is not possible. Second, both VIDUS and ACCESS cohorts are community-recruited non-randomized samples of IDU and HIV-positive drug users and therefore our findings may not be generalizable to all crack cocaine users in local or other settings. Third, from this study, it is not clear whether the participants are using their own mouthpiece, sharing a mouthpiece, or not using a mouthpiece at all when they are sharing crack pipes. Lastly, the data collected were self-reported and may be subject to reporting biases.

In summary, we found that crack pipe sharing is common among people who smoke crack in Vancouver. Difficulty accessing pipes and having acquired a mouthpiece were positively associated with crack pipe sharing. Although many cities worldwide, including Vancouver, have succeeded in providing harm reduction paraphernalia for IDU, similar services for people who smoke crack are not as readily available [20]. Our findings suggest that additional crack pipe distribution efforts are needed to address the risks and harms associated with crack use.

Competing interests

Dr. Julio Montaner has received grants from, served as an ad hoc advisor to, or spoke at various event sponsored by: Abbott, Argos therapeutics, Bioject Inc., Boehringer Ingelheim, BMS, Gilead Sciences, GlaxoSmithKline, Hoffmann-La Roche, Janssen-Ortho, Merck Frosst, Pfizer, Schering, Serono Inc., TheraTechnologies, Tibotec, and Trimeris. Other authors declare that they have no other competing interests.

Authors' contributions

The specific contributions of each author are as follows: LT and TK were responsible for study design; RZ conducted the statistical analyses; LT prepared the first draft of the analysis; All authors provided critical comments on the first draft of the manuscript and approved the final version to be submitted.

Acknowledgements

The authors thank the study participants for their contribution to the research as well as current and past researchers and staff. We would specifically like to thank Deborah Graham, Tricia Collingham, Carmen Rock, Peter Vann, Caitlin Johnston, Steve Kain, and Calvin Lai for their research and administrative assistance, and Dr. Robert Hogg for facilitating access to the British Columbia Centre for Excellence HIV/AIDS Drug Treatment Program data.

Funding for this study was provided by the US National Institutes of Health (R01DA021525) and the Canadian Institutes of Health Research (MOP-79297, RAA-79918). Thomas Kerr is supported by the Michael Smith Foundation. Julio Montaner is supported by the Ministry of Health Services and the Ministry of Healthy Living and Sport, from the Province of British Columbia; through a Knowledge Translation Award from CIHR; and through an Avant-Garde Award (No 1DP1DA026182-01) from the National Institute on Drug Abuse, at the US National Institutes of Health.

References

  • Porter J, Bonilla L. Crack Users' Crack Lips: An Additional HIV Risk Factor. Am J Public Health. 1993;83(10):1490–1491. [PubMed]
  • DeBeck K, Kerr T, Li K, Fischer B, Buxton J, Montaner J, Wood E. Smoking of crack cocaine as a risk factor for HIV infection among people who use injection drugs. CMAJ. 2008;181(9):585–589. [PMC free article] [PubMed]
  • Nyamathi AM, Dixon EL, Robbins W, Smith C, Wiley D, Leake B, Longshore D, Gelberg L. Risk Factors for Hepatitis C Virus Infection Among Homeless Adults. J Gen Intern Med. 2002;17:134–143. doi: 10.1046/j.1525-1497.2002.10415.x. [PMC free article] [PubMed] [Cross Ref]
  • Tortu S, McMahon JM, Pouget ER, Hamid R. Sharing of Noninjection Drug-Use Implements as a Risk Factor for Hepatitis C. Subst Use Misuse. 2004;39(2):211–224. doi: 10.1081/JA-120028488. [PubMed] [Cross Ref]
  • Edlin BR, Irwin KL, Faruque S, McCoy CB, Word C, Serrano Y, Inciardi JA, Bowser BP, Schilling RF. the Multicenter Crack Cocaine and HIV Infection Study Team. Intersecting epidemics - Crack cocaine use and HIV infection among inner-city young adults. N Engl J Med. 1994;331(21):1422–1427. doi: 10.1056/NEJM199411243312106. [PubMed] [Cross Ref]
  • Gardy JL, Johnston JC, Ho Sui SJ, Cook VJ, Shah L, Brodkin E, Rempel S, Moore R, Zhao Y, Holt R, Varhol R, Birol I, Lem M, Sharma MK, Elwood K, Kones SJ, Brinkman FS, Brunham RC, Tang P. Whole-Genome Sequencing and Social-Network Analysis of a Tuberculosis Outbreak. N Engl J Med. 2011;364:730–739. doi: 10.1056/NEJMoa1003176. [PubMed] [Cross Ref]
  • McElroy PD, Rothenberg RB, Varghese R, Woodruff R, Minns GO, Muth SQ, Lambert LA, Ridzon R. A network-informed approach to investigating a tuberculosis outbreak: implications for enhancing contact investigations. Int J Tuberc Lung Dis. 2003;7(12 Suppl 3):S486–493. [PubMed]
  • Leonard L, DeBuneis E, Pelude L, Medd E, Birkett N, Seto J. "I inject less as I have easier access to pipes": Injecting, and sharing of crack-smoking materials, decline as safer crack-smoking resources are distributed. Int J Drug Policy. 2008;19:255–264. doi: 10.1016/j.drugpo.2007.02.008. [PubMed] [Cross Ref]
  • British Columbia Harm Reduction Strategies and Services. Best Practices for British Columbia's Harm Reduction Supply Distribution Program. Vancouver: BC Centre for Disease Control; 2008.
  • Bailey I. Rethinking crack kits for addicts. The Globe and Mail. 2008.
  • Dormer D. Province shuts down free crack pipe program. Calgary Sun. 2011.
  • United Nations Office on Drugs and Crime. World Drug Report 2011. Vienna: United Nations Office on Drugs and Crime; 2011.
  • Werb D, DeBeck K, Kerr T, Li K, Montaner J, Wood E. Modelling crack cocaine use trends over 10 years in a Canadian setting. Drug Alcohol Rev. 2010;29:271–277. doi: 10.1111/j.1465-3362.2009.00145.x. [PubMed] [Cross Ref]
  • Marshall BD, Shoveller JA, Wood E, Patterson TL, Kerr T. Difficulty Accessing Syringes Mediates the Relationship Between Methamphetamine Use and Syringe Sharing Among Young Injection Drug Users. AIDS Behav. 2010. [PMC free article] [PubMed]
  • Health Canada. Canadian Alcohol and Drug Use Monitoring Survey. Ottawa, ON: Office of Drugs and Alcohol Research and Surveillance Controlled Substances and Tobacco Directorate, Health Canada; 2010.
  • British Columbia Harm Reduction Strategies and Services. Crack Pipe Mouthpieces: Questions and Answers. Vancouver: BC Centre for Disease Control; 2010.
  • British Columbia Harm Reduction Strategies and Services. Crack Pipe Push Sticks: Questions and Answers. Vancouver: BC Centre for Disease Control; 2010.
  • Buxton J, Kerr T, Qi J, Montaner J, Wood E. Public crack cocaine smoking and willingness to use a supervised inhalation facility: implications for street disorder. Subst Abuse Treat Prev Policy. 2011;6(4) [PMC free article] [PubMed]
  • Palepu A, Milloy M, Kerr T, Zhang R, Wood E. Homelessness and Adherence to Antiretroviral Therapy among a Cohort of HIV-Infected Injection Drug Users. J Urban Health. 2011;88(3):545–555. doi: 10.1007/s11524-011-9562-9. [PMC free article] [PubMed] [Cross Ref]
  • Haydon E, Fischer B. Crack Use As a Public Health Problem in Canada: Call for an Evaluation of 'Safer Crack Use Kits'. Can J Public Health. 2005;96(3):185–188. [PubMed]

Articles from Substance Abuse Treatment, Prevention, and Policy are provided here courtesy of BioMed Central